학술논문
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
Document Type
Article
Author
Source
In: Communications Biology . (Communications Biology, December 2023, 6(1))
Subject
Language
English
ISSN
23993642